Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2013 | $5 M | No. 2 | $2 to $10 million | equity | SEC | |
| Nov 2010 | $10 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Anacor Pharmaceuticals Inc chose not to state its revenue in its newest notice of a funding round (Apr 2013).
SEC Form D · Apr 2013
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Apr 2013
That is all the official record says: Anacor Pharmaceuticals Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
21 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Aberdare GP II, L.L.C. | Other | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Aberdare II Annex Fund L.P. | Fund or asset manager | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Aberdare Ventures II (Bermuda), L.P. | Venture capital | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Aberdare Ventures II, L.P. | Venture capital | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Care Capital Investments II LP | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Care Capital Offshore Investments II LP | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Lucy Shapiro | Person | not stated | not stated | Held Series A-2 and C preferred stock, director (Form 3, 2010) | SEC Form 3 |
| Paul H. Klingenstein | Person | not stated | not stated | Held Series A-1, B, C, D and E preferred (Form 3, 2010) | SEC Form 3 |
| Rho Capital Partners Inc | Fund or asset manager | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Rho Capital Partners Verwaltungs Gmbh | Fund or asset manager | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Rho Management Trust I | Fund or asset manager | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Rho Management Ventures IV LLC | Venture capital | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Rho Ventures IV Gmbh & Co Beteiligungs KG | Venture capital | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Rho Ventures IV LP | Venture capital | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Rho Ventures IV QP LP | Venture capital | not stated | not stated | Held Series A-1, B, C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| VEF Management IV, LLC | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Venrock Associates IV L.P. | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Venrock Entrepreneurs Fund IV L.P. | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Venrock Management IV, LLC | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Venrock Partners, L.P. | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Venrock Partners Management, LLC | Fund or asset manager | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 2 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Perry | Executive officer | Apr 2013 |
| Geoffrey Parker | Executive officer | Apr 2013 |
| Jacob Plattner | Executive officer | Apr 2013 |
| Kirk Maples | Executive officer | Apr 2013 |
| Lee Zane | Executive officer | Apr 2013 |
| Irwin Heyman | Executive officer | Dec 2010 |
| Anders Hove | Director | Apr 2013 |
| David Perry | Director | Apr 2013 |
| Lucy Shapiro | Director | Apr 2013 |
| Mark Leschly | Director | Apr 2013 |
| Paul Berns | Director | Apr 2013 |
| Paul Klingenstein | Director | Apr 2013 |
| William Rieflin | Director | Apr 2013 |
| Richard Markham | Director | Dec 2010 |
| Zhi Hong | Director | Dec 2010 |